Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: Human glioma cells enhance cell viability and stimulate cytokine production in neutrophils

Journal of Leukocyte Biology

Volumn 73, Issue 3, 2003, Pages 363-368

  Hor, Wei Shio ^a   Huang, Wei Lune ^a   Lin, Yee Shin ^a   Yang, Bei Chang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; IL 6; IL 8

Indexed keywords

ANTIBODY; ANTIBODY CH 11; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL KILLING; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; NEUTROPHIL; PRIORITY JOURNAL; TUMOR ESCAPE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOKINES; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECEPTOR CROSS-TALK; TUMOR CELLS, CULTURED;

EID: 0038362233     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0702375     Document Type: Article

References (36)

1. Wright, S. C., Zhong, J., Larrich, J. W. (1994) Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8, 654-660.
2. Nagata, S., Goldstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
3. Walker, P. R., Saas, P., Dietrich, P. Y. (1998) Tumor expression of Fas ligand (CD95L) and the consequences. Curr. Opin. Immunol. 10, 564-572.
4. Paul, R. W., Saas, P., Dietrich, P. Y. (1997) Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 158, 4521-4524.
5. Strand, S., Hofmann, W. J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., Galle, P. R. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion? Nat. Med. 2, 1361-1366.
6. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J., Tschopp, J. (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363-1366.
7. Seino, K. I., Kayagaki, N., Tsukada, N., Fukao, K., Yagita, H., Okumura, K. (1997) Transplantation of CD95 ligand-expressing grafts: influence of transplantation site and difficulty in protecting allo- and xenografts. Transplantation 64, 1050-1054.
8. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway Jr., C. A., Matis, L. A. (1997) The role of Fas in autoimmune diabetes. Cell 89, 17-24.
9. Suzuki, I., Fink, P. J. (1998) Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187, 123-128.
10. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., Lynch, D. H. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235.
11. Rescigno, M., Piguet, V., Valzasina, B., Lens, S., Zubler, R., French, L., Kindler, V., Tschopp, J., Ricciardi-Castagnoli, P. (2000) Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role of Fas ligand in inflammatory responses. J. Exp. Med. 192, 1661-1668.
12. Gao, Y., Herndon, J. M., Zhang, H., Griffith, T. S., Ferguson, T. A. (1998) Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188, 887-896.
13. Chio, C. C., Wang, Y. S., Chen, Y. L., Lin, S. J., Yang, B. C. (2001) Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumor infiltrating cells, and liver damage but accelerates tumor formation in nude mice. Br. J. Cancer 85, 1185-1192.
14. Chen, Y. L., Wang, J. Y., Chen, S. H., Yang, B. C. (2002) Granulocytes mediate the FasL-associated apoptosis during lung metastasis of melanoma that determines the metastatic behavior. Br. J. Cancer 87, 359-365.
15. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A. L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J., Dietrich, P. Y. (1997) Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99, 1173-1178.
16. Gratas, C., Tohma, Y., van Meir, E. G., Klein, M., Tenan, M., Ishii, N., Tachibana, O., Kleihues, P., Ohgaki, H. (1997) Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol. 7, 863-869.
17. Fossati, G., Ricevuti, G., Edwards, S. W., Walker, C., Dalton, A., Rossi, M. L. (1999) Neutrophil infiltration into human gliomas. Acta Neuropathol. (Berl.) 98, 349-354.
18. Hohlbaum, A. M., Gregory, M. S., Ju, S. T., Marshak-Rothstein, A. (2001) Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 167, 6217-6224.
19. Metcalf, J. A., Gallin, J. I., Nauseef, W. M., Root, R. K. (1986) Laboratory Manual of Neutrophil Function, New York, NY, Raven.
20. Buckley, M. G., Williams, C. M., Thompson, J., Pryor, P., Ray, K., Butterfield, J. H., Coleman, J. W. (1995) IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 84, 410-415.
21. Mattern, T., Thanhauser, A., Reiling, N., Toellner, K. M., Duchrow, M., Kusumoto, S., Rietschel, E. T., Ernst, M., Brade, H., Flad, H. D. (1994) Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J. Immunol. 153, 2996-3004.
22. Yang, B. C., Wang, Y. S., Wang, C. H., Lin, H. H., Tang, M. J., Yang, T. L. (1999) Insulin-elicited transient apoptosis in serum-starved glioma cells involved Fas/Fas-L and Bcl-2. Cell Biol. Int. 23, 533-540.
23. Choi, C., Xu, X., Oh, J. W., Lee, S. J., Gillespie, G. Y., Park, H., Jo, H., Benveniste, E. N. (2001) Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res. 61, 3084-3091.
24. Baggiolini, M., Walz, A., Kunkel, S. L. (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045-1049.
25. Desbaillets, I., Diserens, A. C., Tribolet, N., Hamou, M. F., van Meir, E. G. (1997) Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 186, 1201-1212.
26. Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., Klebanoff, S. J. (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440.
27. Hsieh, S. C., Huang, M. H., Tsai, C. Y., Tsai, Y. Y., Tsai, S. T., Sun, K. H., Yu, H. S., Han, S. H., Yu, C. L. (1997) The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils. Biochem. Biophys. Res. Commun. 233, 700-706.
28. Zhang, Y., Ramos, B. F., Jakschik, B., Baganoff, M. P., Deppeler, C. L., Meyer, D. M., Widomski, D. L., Fretland, D. J., Bolanowski, M. A. (1995) Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment. Inflammation 19, 119-132.
29. Kettritz, R., Gaido, M. L., Haller, H., Luft, F. C., Jennette, C. J., Falk, R. J. (1998) Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int. 53, 84-91.
30. Biffl, W. L., Moore, E. E., Moore, F. A., Barnett, C. C., Carls, V. S., Peterson, V. M. (1996) Interleukin-6 delays neutrophil apoptosis. Arch. Surg. 131, 24-30.
31. Takeda, Y., Watanabe, H., Yonehara, S., Yamashita, T., Saito, S., Sendo, F. (1993) Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int. Immunol. 5, 691-694.
32. Kettritz, R., Falk, R. J., Jennette, J. C., Gaido, M. L. (1997) Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis. J. Am. Soc. Nephrol. 8, 1091-1100.
33. Graf, M. R., Prins, R. M., Merchant, R. E. (2001) IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity. J. Immunol. 166, 121-129.
34. Egeter, O., Mocikat, R., Ghoreschi, K., Dieckmann, A., Röcken, M. (2000) Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice. Cancer Res. 60, 1515-1520.
35. Uramoto, H., Osaki, T., Inoue, M., Taga, S., Takenoyama, M., Hanagiri, T., Yoshino, I., Nakanishi, R., Ichiyoshi, Y., Yasumoto, K. (1999) Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients. Eur. J. Cancer 35, 1462-1465.
36. Owen-Schaub, L. B., van Golen, K. L., Hill, L. L., Price, J. E. (1998) Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 188, 1717-1723.